Related Experiment Video
Updated: Apr 20, 2026

11:07
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
8.8K
Local recurrence map to guide target volume delineation after radical prostatectomy.
Jingya Wang1, Rajat Kudchadker1, Seungtaek Choi1
1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Practical Radiation Oncology
|November 20, 2014
Summary
Recurrent prostate cancer after surgery can appear in various locations. Understanding these patterns helps improve radiation therapy planning for better treatment outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Imaging
Background:
- Radical prostatectomy (RP) is a common treatment for prostate cancer.
- Recurrent prostate cancer after RP requires precise radiation therapy planning.
- Accurate contouring of the prostatic fossa clinical target volume (PF-CTV) is crucial for effective treatment.
Purpose of the Study:
- To map the anatomical locations of recurrent prostate cancer after RP.
- To guide the contouring of the PF-CTV in cases of non-visible recurrence or when MRI is unavailable.
- To improve target definition for conformal radiation therapy in the adjuvant or salvage setting.
Main Methods:
- Selected ten patients with MRI-detected, biopsy-proven local recurrences post-RP.
- Delineated recurrence areas on MRI and mapped them onto template images.
- Evaluated coverage of recurrence areas using RTOG-consensus PF-CTV contours on CT templates.
Main Results:
- Recurrences varied significantly in superoinferior and anteroposterior directions.
- Locations ranged from the superior retrovesical region to the posterior urogenital diaphragm.
- RTOG-PF-CTV contours showed marginal or lacking coverage for posterolateral and inferior recurrences.
Conclusions:
- Prostate cancer recurrence locations exhibit considerable variation post-RP.
- RTOG-consensus PF-CTV contours may require modifications, especially in posterolateral and inferior regions.
- Improved target definition can enhance conformal radiation therapy for recurrent prostate cancer.

